Shopping Cart
Remove All
Your shopping cart is currently empty
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) that specifically targets BCMA (B cell maturation antigen) and CD3ɛ. By redirecting T cells to cells expressing BCMA, Pacanalotamab facilitates the T-cell mediated lysis of human multiple myeloma (MM) cell lines [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $498 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $1,230 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $1,990 | 2-4 weeks | 2-4 weeks |
| Description | Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) that specifically targets BCMA (B cell maturation antigen) and CD3ɛ. By redirecting T cells to cells expressing BCMA, Pacanalotamab facilitates the T-cell mediated lysis of human multiple myeloma (MM) cell lines [1]. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2251756-52-0 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.